26073123|t|Oxidative stress, mitochondrial and proteostasis malfunction in adrenoleukodystrophy: A paradigm for axonal degeneration.
26073123|a|Peroxisomal and mitochondrial malfunction, which are highly intertwined through redox regulation, in combination with defective proteostasis, are hallmarks of the most prevalent multifactorial neurodegenerative diseases-including Alzheimer's (AD) and Parkinson's disease (PD)-and of the aging process, and are also found in inherited conditions. Here we review the interplay between oxidative stress and axonal degeneration, taking as groundwork recent findings on pathomechanisms of the peroxisomal neurometabolic disease adrenoleukodystrophy (X-ALD). We explore the impact of chronic redox imbalance caused by the excess of very long-chain fatty acids (VLCFA) on mitochondrial respiration and biogenesis, and discuss how this impairs protein quality control mechanisms essential for neural cell survival, such as the proteasome and autophagy systems. As consequence, prime molecular targets in the pathogenetic cascade emerge, such as the SIRT1/PGC-1alpha axis of mitochondrial biogenesis, and the inhibitor of autophagy mTOR. Thus, we propose that mitochondria-targeted antioxidants; mitochondrial biogenesis boosters such as the antidiabetic pioglitazone and the SIRT1 ligand resveratrol; and the autophagy activator temsirolimus, a derivative of the mTOR inhibitor rapamycin, hold promise as disease-modifying therapies for X-ALD. 
26073123	64	84	adrenoleukodystrophy	Disease	MESH:D000326
26073123	101	120	axonal degeneration	Disease	MESH:D009410
26073123	138	163	mitochondrial malfunction	Disease	MESH:D028361
26073123	315	341	neurodegenerative diseases	Disease	MESH:D019636
26073123	352	363	Alzheimer's	Disease	MESH:D000544
26073123	365	367	AD	Disease	MESH:D000544
26073123	373	392	Parkinson's disease	Disease	MESH:D010300
26073123	394	396	PD	Disease	MESH:D010300
26073123	526	545	axonal degeneration	Disease	MESH:D009410
26073123	610	644	peroxisomal neurometabolic disease	Disease	MESH:D018901
26073123	645	665	adrenoleukodystrophy	Disease	MESH:D000326
26073123	667	672	X-ALD	Disease	MESH:D000326
26073123	753	775	long-chain fatty acids	Chemical	-
26073123	777	782	VLCFA	Chemical	MESH:C017364
26073123	1063	1068	SIRT1	Gene	23411
26073123	1069	1079	PGC-1alpha	Gene	10891
26073123	1145	1149	mTOR	Gene	2475
26073123	1268	1280	pioglitazone	Chemical	MESH:D000077205
26073123	1289	1294	SIRT1	Gene	23411
26073123	1302	1313	resveratrol	Chemical	MESH:D000077185
26073123	1343	1355	temsirolimus	Chemical	MESH:C401859
26073123	1377	1381	mTOR	Gene	2475
26073123	1392	1401	rapamycin	Chemical	MESH:D020123
26073123	1451	1456	X-ALD	Disease	MESH:D000326
26073123	Association	10891	23411
26073123	Negative_Correlation	MESH:D000077205	MESH:D000326
26073123	Negative_Correlation	MESH:C401859	2475
26073123	Cotreatment	MESH:C401859	MESH:D020123
26073123	Association	MESH:D000326	23411
26073123	Negative_Correlation	MESH:C401859	MESH:D000326
26073123	Association	MESH:D000077185	23411
26073123	Negative_Correlation	MESH:D000077185	MESH:D000326
26073123	Negative_Correlation	MESH:D020123	2475
26073123	Negative_Correlation	MESH:D020123	MESH:D000326

